GO
Loading...

Savient Bulls Come Back for More

Savient Pharmaceuticals

Biotech
Getty Images
Biotech

has been taken to the woodshed, but recently it’s turned bullish.

On Monday, buyers jumped into the December 2 calls, with 2,000 pricing for $0.12 to $0.16, and traders continued to snap up those contracts yesterday.This time, another 4,100 traded with the largest block pricing for $0.31, according to OptionMonster’s real-time tracking systems.

Savient Pharmaceuticals

Calls lock in the price investors pay to buy stock, so they can generate some nice leverage if the shares continue climb. If no rally occurs, however, those options can expire worthless.

Savient shares fell 1.34 percent to $2.06 yesterday after trading as high as $2.24 earlier in the session. The stock has come back from the dead, roughly tripling since July as small-cap drug developers have come into favor.

Calls outnumbered puts by about 21,000 to 1,400, reflecting the day’s bullish sentiment. Total volume was almost triple the daily average.

—By CNBC Contributor Pete Najarian

Additional News: Biotech—Outperforming for the Right Reasons

Additional Views: Bulls Target CNO Financial at Highs: Najarian


___________________________

___________________________
Options Trading School:

___________________________

Pete Najarianis a professional investor, CNBC contributor, regular co-host of CNBC’s “ Fast Money ” and co-founder of OptionMonster.com . Najarian has no positions in SVNT.

___________________________

Disclaimer